Paul Sohmer, who most recently led Viracor-IBT Laboratories, has been appointed to replace Eric Bouvier as president and CEO of BG Medicine. The Waltham, Mass.-based cardiovascular diagnostics firm also posted $0.8 million in sales from its BGM Galectin-3 assay during its fiscal first quarter, a rise from $0.4 million in the same period last year.

Related Summaries